Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helio S Sader

Showing results (361-370 of 420) with videos related to

Pageof 42
Sort By:
Antimicrobial Agents and Chemotherapy|May 29, 2014
Decreased ceftriaxone susceptibility in emerging (35B and 6C) and persisting (19A) Streptococcus pneumoniae serotypes in the United States, 2011-2012: ceftaroline remains active in vitro among β-lactam agentsRodrigo E Mendes, Donald Biek, Ian A Critchley, et al.
Journal of Global Antimicrobial Resistance|December 13, 2016
Prevalence of macrolide-lincosamide resistance and multidrug resistance phenotypes in streptococcal isolates causing infections in European hospitals: Evaluation of the in vitro activity of oritavancin and comparator agentsRodrigo E Mendes, Mariana Castanheira, David J Farrell, et al.
Diagnostic Microbiology and Infectious Disease|April 6, 2017
Activity of telavancin against Gram-positive pathogens isolated from bone and joint infections in North American, Latin American, European and Asia-Pacific nationsRonald N Jones, Robert K Flamm, Mariana Castanheira, et al.
Diagnostic Microbiology and Infectious Disease|July 13, 2015
Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010-2013)Helio S Sader, Mariana Castanheira, Robert K Flamm, et al.
Diagnostic Microbiology and Infectious Disease|August 23, 2011
Plasmid-borne vga(A)-encoding gene in methicillin-resistant Staphylococcus aureus ST398 recovered from swine and a swine farmer in the United StatesRodrigo E Mendes, Tara C Smith, Lalitagauri Deshpande, et al.
International Journal of Antimicrobial Agents|June 14, 2016
Tigecycline antimicrobial activity tested against clinical bacteria from Latin American medical centres: results from SENTRY Antimicrobial Surveillance Program (2011-2014)Helio S Sader, Mariana Castanheira, David J Farrell, et al.
The Pediatric Infectious Disease Journal|April 14, 2017
Ceftaroline Activity Tested Against Bacterial Isolates Causing Community-acquired Respiratory Tract Infections and Skin and Skin Structure Infections in Pediatric Patients From United States Hospitals: 2012-2014Michael A Pfaller, Rodrigo E Mendes, Mariana Castanheira, et al.
The Journal of Antimicrobial Chemotherapy|August 26, 2021
Investigation of mechanisms responsible for decreased susceptibility of aztreonam/avibactam activity in clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019Rodrigo E Mendes, Timothy B Doyle, Jennifer M Streit, et al.
International Journal of Antimicrobial Agents|May 10, 2015
Ceftazidime/avibactam tested against Gram-negative bacteria from intensive care unit (ICU) and non-ICU patients, including those with ventilator-associated pneumoniaHelio S Sader, Mariana Castanheira, Robert K Flamm, et al.
The Journal of Antimicrobial Chemotherapy|September 10, 2016
Longitudinal (2001-14) analysis of enterococci and VRE causing invasive infections in European and US hospitals, including a contemporary (2010-13) analysis of oritavancin in vitro potencyRodrigo E Mendes, Mariana Castanheira, David J Farrell, et al.
Pageof 42

Showing results (361-370 of 420) with videos related to

Sort By:
Pageof 42
Antimicrobial Agents and Chemotherapy|May 29, 2014
Decreased ceftriaxone susceptibility in emerging (35B and 6C) and persisting (19A) Streptococcus pneumoniae serotypes in the United States, 2011-2012: ceftaroline remains active in vitro among β-lactam agentsRodrigo E Mendes, Donald Biek, Ian A Critchley, et al.
Journal of Global Antimicrobial Resistance|December 13, 2016
Prevalence of macrolide-lincosamide resistance and multidrug resistance phenotypes in streptococcal isolates causing infections in European hospitals: Evaluation of the in vitro activity of oritavancin and comparator agentsRodrigo E Mendes, Mariana Castanheira, David J Farrell, et al.
Diagnostic Microbiology and Infectious Disease|April 6, 2017
Activity of telavancin against Gram-positive pathogens isolated from bone and joint infections in North American, Latin American, European and Asia-Pacific nationsRonald N Jones, Robert K Flamm, Mariana Castanheira, et al.
Diagnostic Microbiology and Infectious Disease|July 13, 2015
Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010-2013)Helio S Sader, Mariana Castanheira, Robert K Flamm, et al.
Diagnostic Microbiology and Infectious Disease|August 23, 2011
Plasmid-borne vga(A)-encoding gene in methicillin-resistant Staphylococcus aureus ST398 recovered from swine and a swine farmer in the United StatesRodrigo E Mendes, Tara C Smith, Lalitagauri Deshpande, et al.
International Journal of Antimicrobial Agents|June 14, 2016
Tigecycline antimicrobial activity tested against clinical bacteria from Latin American medical centres: results from SENTRY Antimicrobial Surveillance Program (2011-2014)Helio S Sader, Mariana Castanheira, David J Farrell, et al.
The Pediatric Infectious Disease Journal|April 14, 2017
Ceftaroline Activity Tested Against Bacterial Isolates Causing Community-acquired Respiratory Tract Infections and Skin and Skin Structure Infections in Pediatric Patients From United States Hospitals: 2012-2014Michael A Pfaller, Rodrigo E Mendes, Mariana Castanheira, et al.
The Journal of Antimicrobial Chemotherapy|August 26, 2021
Investigation of mechanisms responsible for decreased susceptibility of aztreonam/avibactam activity in clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019Rodrigo E Mendes, Timothy B Doyle, Jennifer M Streit, et al.
International Journal of Antimicrobial Agents|May 10, 2015
Ceftazidime/avibactam tested against Gram-negative bacteria from intensive care unit (ICU) and non-ICU patients, including those with ventilator-associated pneumoniaHelio S Sader, Mariana Castanheira, Robert K Flamm, et al.
The Journal of Antimicrobial Chemotherapy|September 10, 2016
Longitudinal (2001-14) analysis of enterococci and VRE causing invasive infections in European and US hospitals, including a contemporary (2010-13) analysis of oritavancin in vitro potencyRodrigo E Mendes, Mariana Castanheira, David J Farrell, et al.
Pageof 42